Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medlens Innovations is an Indian medical technology company focused on eradicating preventable blindness through artificial intelligence and portable diagnostic hardware. The company develops AI-powered screening tools designed to detect retinal diseases such as diabetic retinopathy and glaucoma at the primary care level. Their flagship platform integrates low-cost fundus imaging with deep learning algorithms to provide immediate, actionable reports. By decentralizing eye screenings, Medlens Innovations aims to bridge the gap in specialist availability and improve patient outcomes in resource-limited settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medlens Innovations.